“Real-Life Comparative Effectiveness of IL-23 Inhibitors in the Treatment of Moderate to Severe Psoriasis: A Multicenter Experience”, Dermatol Pract Concept, vol. 14, no. 3, p. e2024179, Jul. 2024, doi: 10.5826/dpc.1403a179.